The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Gene therapy: Comprehensive overview and therapeutic applications
Abstract
Gene therapy is the product of man's quest to eliminate diseases. Gene therapy has three facets namely, gene silencing using siRNA, shRNA and miRNA, gene replacement where the desired gene in the form of plasmids and viral vectors, are directly administered and finally gene editing based therapy where mutations are modified using specific nucleases such as zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regulatory interspaced short tandem repeats (CRISPR)/CRISPR-associated protein (Cas)-associated nucleases. Transfer of gene is either through transformation where under specific conditions the gene is directly taken up by the bacterial cells, transduction where a bacteriophage is used to transfer the genetic material and lastly transfection that involves forceful delivery of gene using either viral or non-viral vectors. The non- viral transfection methods are subdivided into physical, chemical and biological. The physical method includes electroporation, biolistic, microinjection, laser, elevated temperature, ultrasound and hydrodynamic gene transfer. The chemical methods utilize calcium- phosphate, DAE-dextran, liposomes and nanoparticles for transfection. The biological methods are increasingly using viruses for gene transfer, these viruses could either integrate within the genome of the host cell conferring a stable gene expression, whereas few other non-integrating viruses are episomal and their expression is diluted proportional to the cell division. So far, gene therapy has been wielded in a plethora of diseases. However, coherent and innocuous delivery of genes is among the major hurdles in the use of this promising therapy. Hence this literature aims to highlight the current options available for gene transfer along with the advantages and limitations of every method.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Gaj, T., Gersbach, C. A., & Barbas, C. F. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.04.004 · Cited by 3,820
Cellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859
Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0669-6 · Cited by 2,383
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y.-S., Domm, J., Eustace, B. K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031054 · Cited by 1,962
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0089-y · Cited by 1,715
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017) · BioDrugs · doi:10.1007/s40259-017-0234-5 · Cited by 1,362
Engineering adeno-associated virus vectors for gene therapy
Li, C., & Samulski, R. J. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0205-4 · Cited by 1,175
Electroporation and Electrofusion in Cell Biology
(1989) · Springer eBooks · doi:10.1007/978-1-4899-2528-2 · Cited by 942
Clinical use of lentiviral vectors
Milone, M. C., & O’Doherty, U. (2018) · Leukemia · doi:10.1038/s41375-018-0106-0 · Cited by 930
Gene therapy using adeno-associated virus vectors
Daya, S., & Berns, K. I. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-08 · Cited by 926
Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111708 · Cited by 909
Self-citationGene therapy clinical trials worldwide to 2017: An update
Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M., & Abedi, M. R. (2018) · The Journal of Gene Medicine · doi:10.1002/jgm.3015 · Cited by 903
Therapeutic applications of selenium nanoparticles
Khurana, A., Tekula, S., Saifi, M. A., Venkatesh, P., & Godugu, C. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.146 · Cited by 818
Self-citationImmune Responses to Viral Gene Therapy Vectors
Shirley, J. L., de Jong, Y. P., Terhorst, C., & Herzog, R. W. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.001 · Cited by 788
Non Viral Vectors in Gene Therapy- An Overview
Ramamoorth, M. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/10443.5394 · Cited by 761
Selective Cell Targeting with Light-Absorbing Microparticles and Nanoparticles
Pitsillides, C. M., Joe, E. K., Wei, X., Anderson, R. R., & Lin, C. P. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)75128-5 · Cited by 753
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
Maeder, M. L., Stefanidakis, M., Wilson, C. J., Baral, R., Barrera, L. A., Bounoutas, G. S., Bumcrot, D., Chao, H., Ciulla, D. M., DaSilva, J. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0327-9 · Cited by 707
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
Thompson, A. A., Walters, M. C., Kwiatkowski, J., Rasko, J. E. J., Ribeil, J.-A., Hongeng, S., Magrin, E., Schiller, G. J., Payen, E., Semeraro, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705342 · Cited by 684
LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70039-4 · Cited by 681
Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
Hacein-Bey-Abina, S., Hauer, J., Lim, A., Picard, C., Wang, G. P., Berry, C. C., Martinache, C., Rieux-Laucat, F., Latour, S., Belohradsky, B. H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000164 · Cited by 639
Vertical silicon nanowires as a universal platform for delivering biomolecules into living cells
Shalek, A. K., Robinson, J. T., Karp, E. S., Lee, J. S., Ahn, D.-R., Yoon, M.-H., Sutton, A., Jorgolli, M., Gertner, R. S., Gujral, T. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909350107 · Cited by 569
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia
Grossman, M., Rader, D. J., Muller, D. W. M., Kolansky, D. M., Kozarsky, K., Clark, B. J., Stein, E. A., Lupien, P. J., Brewer, H. B., Raper, S. E., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1148 · Cited by 530
Structure of PAMAM Dendrimers: Generations 1 through 11
Maiti, P. K., Çaǧın, T., Wang, G., & Goddard, W. A. (2004) · Macromolecules · doi:10.1021/ma035629b · Cited by 525
Gene Therapy for Cancer Treatment: Past, Present and Future
Cross, D., & Burmester, J. K. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.3.218 · Cited by 455
Gene therapy and DNA delivery systems
Ibraheem, D., Elaissari, A., & Fessi, H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.041 · Cited by 454
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease
Esrick, E. B., Lehmann, L. E., Biffi, A., Achebe, M., Brendel, C., Ciuculescu, M. F., Daley, H., MacKinnon, B., Morris, E., Federico, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029392 · Cited by 449
Liposomes for use in gene delivery
Balazs, D. A., & Godbey, W. (2011) · Journal of Drug Delivery · doi:10.1155/2011/326497 · Cited by 441
Biological effects of low level laser therapy.
Farivar, S., Malekshahabi, T., & Shiari, R. (2014) · PubMed · Cited by 438
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
Hacein-Bey-Abina, S., Pai, S.-Y., Gaspar, H. B., Armant, M., Berry, C. C., Blanche, S., Bleesing, J., Blondeau, J., de Boer, H., Buckland, K. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404588 · Cited by 412
Calcium cycling proteins and heart failure: mechanisms and therapeutics
Marks, A. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62834 · Cited by 402
Alton, E. W. F. W., Middleton, P. G., Caplen, N. J., Smith, S. N., Steel, D. M., Munkonge, F. M., Jeffery, P. K., Geddes, D. M., Hart, S. L., Williamson, R., et al. (1993) · Nature Genetics · doi:10.1038/ng1093-135 · Cited by 402
Current Progress in Gene Delivery Technology Based on Chemical Methods and Nano-Carriers
Jin, L., Zeng, X., Liu, M., Deng, Y., & He, N. (2014) · Theranostics · doi:10.7150/thno.6914 · Cited by 388
New Modalities for Challenging Targets in Drug Discovery
Valeur, E., Guéret, S. M., Adihou, H., Gopalakrishnan, R., Lemurell, M., Waldmann, H., Grossmann, T. N., & Plowright, A. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611914 · Cited by 382
Viral vectors: from virology to transgene expression
Bouard, D., Alazard‐Dany, N., & Cosset, F. (2009) · British Journal of Pharmacology · doi:10.1038/bjp.2008.349 · Cited by 360
Utilising inorganic nanocarriers for gene delivery
Loh, X. J., Lee, T.-C., Dou, Q., & Deen, G. R. (2016) · Biomaterials Science · doi:10.1039/c5bm00277j · Cited by 355
Gene therapy: advances, challenges and perspectives
Gonçalves, G. A. R., & Paiva, R. D. M. A. (2017) · Einstein (São Paulo) · doi:10.1590/s1679-45082017rb4024 · Cited by 351
Hydrodynamic Gene Delivery: Its Principles and Applications
Suda, T., & Liu, D. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300314 · Cited by 347
Gene Therapy Leaves a Vicious Cycle
Goswami, R., Subramanian, G., Silayeva, L., Newkirk, I., Doctor, D., Chawla, K., Chattopadhyay, S., Chandra, D., Chilukuri, N., & Betapudi, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00297 · Cited by 347
Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential
Escors, D., & Breckpot, K. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0063-4 · Cited by 344
Adenovirus: The First Effective In Vivo Gene Delivery Vector
Crystal, R. G. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.2527 · Cited by 341
Lentiviral vectors: basic to translational
Sakuma, T., Barry, M. A., & Ikeda, Y. (2012) · Biochemical Journal · doi:10.1042/bj20120146 · Cited by 336
The once and future gene therapy
Bulaklak, K., & Gersbach, C. A. (2020) · Nature Communications · doi:10.1038/s41467-020-19505-2 · Cited by 321
Regulated Delivery of Therapeutic Proteins After in Vivo Somatic Cell Gene Transfer
Ye, X., Rivera, V. M., Zoltick, P., Cerasoli, F., Schnell, M. A., Gao, G.-P., Hughes, J. V., Gilman, M., & Wilson, J. M. (1999) · Science · doi:10.1126/science.283.5398.88 · Cited by 308
Role of nanotechnology behind the success of mRNA vaccines for COVID-19
Khurana, A., Allawadhi, P., Khurana, I., Allwadhi, S., Weiskirchen, R., Banothu, A. K., Chhabra, D., Joshi, K., & Bharani, K. K. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101142 · Cited by 284
Self-citationLong-Term Clinical Improvement in MPTP-Lesioned Primates after Gene Therapy with AAV-hAADC
Bankiewicz, K. S., Forsayeth, J., Eberling, J. L., Sanchez-Pernaute, R., Pivirotto, P., Bringas, J., Herscovitch, P., Carson, R. E., Eckelman, W., Reutter, B., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.005 · Cited by 282
Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon
Zakeri, A., Kouhbanani, M. A. J., Beheshtkhoo, N., Beigi, V., Mousavi, S. M., Hashemi, S. A. R., Karimi Zade, A., Amani, A. M., Savardashtaki, A., Mirzaei, E., et al. (2018) · Nano Reviews & Experiments · doi:10.1080/20022727.2018.1488497 · Cited by 280
Park, H., Oh, J., Shim, G., Cho, B., Chang, Y., Kim, S., Baek, S., Kim, H., Shin, J., Choi, H., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0352-0 · Cited by 272
New Advances in General Biomedical Applications of PAMAM Dendrimers
Araújo, R. V. D., Santos, S. D. S., Igne Ferreira, E., & Giarolla, J. (2018) · Molecules · doi:10.3390/molecules23112849 · Cited by 265
Cationic lipid-mediated transfection of cells in culture requires mitotic activity
Mortimer, I., Tam, P., MacLachlan, I., Graham, R. W., Saravolac, E. G., & Joshi, P. B. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300837 · Cited by 256
Kordower, J. H., Herzog, C. D., Dass, B., Bakay, R. A. E., Stansell, J., Gasmi, M., & Bartus, R. T. (2006) · Annals of Neurology · doi:10.1002/ana.21032 · Cited by 252
Recent Advances in Novel Drug Carrier Systems
(2012) · InTech eBooks · doi:10.5772/2889 · Cited by 247
Gene therapy for cancer: present status and future perspective
Amer, M. H. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-27 · Cited by 244
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency
De Ravin, S. S., Wu, X., Moir, S., Kardava, L., Anaya-O’Brien, S., Kwatemaa, N., Littel, P., Theobald, N., Choi, U., Su, L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8856 · Cited by 244
Recent trends in cancer therapy: A review on the current state of gene delivery
Yahya, E. B., & Alqadhi, A. M. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119087 · Cited by 235
Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV e6‐e7 anti‐sense RNA
von Knebel Doeberitz, M., Rittmüller, C., Hausen, H. Z., & dürst, M. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510527 · Cited by 223
Vectors and delivery systems in gene therapy.
Gardlík, R., Pálffy, R., Hodosy, J., Lukács, J., Turňa, J., & Celec, P. (2005) · PubMed · Cited by 219
Delivery systems for gene therapy
Mali, S. (2013) · Indian Journal of Human Genetics · doi:10.4103/0971-6866.112870 · Cited by 206
Eliyahu, H., Barenholz, Y., & Domb, A. J. (2005) · Molecules · doi:10.3390/10010034 · Cited by 201
Zhang, Y., Ma, S., Liu, X., Xu, Y., Zhao, J., Si, X., Li, H., Huang, Z., Wang, Z., Tang, Z., et al. (2021) · Advanced Materials · doi:10.1002/adma.202007293 · Cited by 199
Persistent Human Papillomavirus Infection
Della Fera, A. N., Warburton, A., Coursey, T. L., Khurana, S., & McBride, A. A. (2021) · Viruses · doi:10.3390/v13020321 · Cited by 199
Physical Non-Viral Gene Delivery Methods for Tissue Engineering
Mellott, A. J., Forrest, M. L., & Detamore, M. S. (2013) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0678-1 · Cited by 196
Exosomes and the Emerging Field of Exosome-Based Gene Therapy
O’Loughlin, A., Woffindale, C., & Wood, M. (2012) · Current Gene Therapy · doi:10.2174/156652312802083594 · Cited by 193
The nuclear serine/threonine protein kinase DNA-PK.
Anderson, C. W., & Lees‐Miller, S. P. (1992) · PubMed · Cited by 191
Electroporation-Mediated Gene Delivery
Young, J. L., & Dean, D. A. (2015) · Advances in Genetics · doi:10.1016/bs.adgen.2014.10.003 · Cited by 187
Pearson, T. S., Gupta, N., San Sebastian, W., Imamura-Ching, J., Viehoever, A., Grijalvo-Perez, A., Fay, A. J., Seth, N., Lundy, S. M., Seo, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24524-8 · Cited by 186
Carbon nanotubes as vectors for gene therapy: Past achievements, present challenges and future goals
Bates, K., & Kostarelos, K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.003 · Cited by 181
Vargas, J. E., Chicaybam, L., Stein, R. T., Tanuri, A., Cañedo, A. D., & Bonamino, M. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1047-x · Cited by 180
In vivo gene delivery by cationic tetraamino fullerene
Maeda-Mamiya, R., Noiri, E., Isobe, H., Nakanishi, W., Okamoto, K., Doi, K., Sugaya, T., Izumi, T., Homma, T., & Nakamura, E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909223107 · Cited by 179
Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System
Pérez-Martínez, F. C., Guerra, J., Posadas, I., & Ceña, V. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0364-7 · Cited by 177
Update on clinical gene therapy for hemophilia
Perrin, G. Q., Herzog, R. W., & Markusic, D. M. (2019) · Blood · doi:10.1182/blood-2018-07-820720 · Cited by 175
Lipid and polymeric carrier-mediated nucleic acid delivery
Zhu, L., & Mahato, R. I. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.513969 · Cited by 169
Current Advances in Retroviral Gene Therapy
Yi, Y., Noh, M. J., & Lee, K. H. (2011) · Current Gene Therapy · doi:10.2174/156652311795684740 · Cited by 169
Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review
Indoria, S., Singh, V., & Hsieh, M.-F. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119314 · Cited by 168
Self-citationPoly(amidoamine) dendrimers: covalent and supramolecular synthesis
Lyu, Z., Ding, L., Huang, A. Y.-T., Kao, C.-L., & Peng, L. (2019) · Materials Today Chemistry · doi:10.1016/j.mtchem.2019.04.004 · Cited by 166
A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene
Kemaladewi, D. U., Bassi, P. S., Erwood, S., Al-Basha, D., Gawlik, K. I., Lindsay, K., Hyatt, E., Kember, R., Place, K. M., Marks, R. M., et al. (2019) · Nature · doi:10.1038/s41586-019-1430-x · Cited by 163
Human gene therapy: a brief overview of the genetic revolution.
Misra, S. (2013) · PubMed · Cited by 159
Targeted delivery of therapeutic agents to the heart
Sahoo, S., Kariya, T., & Ishikawa, K. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00499-9 · Cited by 159
Boguski, M. S., Tolstoshev, C. M., & Bassett, D. E. (1994) · Science · doi:10.1126/science.8091218 · Cited by 158
Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates
Milani, M., Annoni, A., Moalli, F., Liu, T., Cesana, D., Calabria, A., Bartolaccini, S., Biffi, M., Russo, F., Visigalli, I., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav7325 · Cited by 153
Extracellular and intracellular barriers in non-viral gene delivery
Ruponen, M. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.004 · Cited by 151
Gene therapies development: slow progress and promising prospect
Hanna, E., Rémuzat, C., Auquier, P., & Toumi, M. (2017) · Journal of Market Access & Health Policy · doi:10.1080/20016689.2017.1265293 · Cited by 151
Gene therapy for the treatment of heart failure: promise postponed
Hulot, J.-S., Ishikawa, K., & Hajjar, R. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw019 · Cited by 150
Fusion dynamics of cubosome nanocarriers with model cell membranes
Dyett, B., Yu, H., Strachan, J. B., Drummond, C. J., & Conn, C. E. (2019) · Nature Communications · doi:10.1038/s41467-019-12508-8 · Cited by 141
Isoproterenol‐induced cardiac ischemia and fibrosis: Plant‐based approaches for intervention
Allawadhi, P., Khurana, A., Sayed, N., Kumari, P., & Godugu, C. (2018) · Phytotherapy Research · doi:10.1002/ptr.6152 · Cited by 140
Self-citationChow, Y. T., Chen, S., Wang, R., Liu, C., Kong, C., Li, R. A., Cheng, S. H., & Sun, D. B. (2016) · Scientific Reports · doi:10.1038/srep24127 · Cited by 139
Gene therapy: a double-edged sword with great powers
Tang, R., & Xu, Z. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03834-3 · Cited by 134
Jerjes, W., Theodossiou, T. A., Hirschberg, H., Høgset, A., Weyergang, A., Selbo, P. K., Hamdoon, Z., Hopper, C., & Berg, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020528 · Cited by 128
Cao, X., Wang, J., Deng, W., Chen, J., Wang, Y., Zhou, J., Du, P., Xu, W., Wang, Q., Wang, Q., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25330-x · Cited by 127
Xu, W., Jiang, X., & Huang, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-64046-8.00282-2 · Cited by 124
Gene Therapy for Infectious Diseases
Bunnell, B. A., & Morgan, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.42 · Cited by 123
Harm, ethics committees and the gene therapy death
Savulescu, J. (2001) · Journal of Medical Ethics · doi:10.1136/jme.27.3.148 · Cited by 116
Sonoporation: Gene transfer using ultrasound
Tomizawa, M. (2013) · World Journal of Methodology · doi:10.5662/wjm.v3.i4.39 · Cited by 112
Production, Processing, and Characterization of Synthetic AAV Gene Therapy Vectors
Andari, J. E., & Grimm, D. (2020) · Biotechnology Journal · doi:10.1002/biot.202000025 · Cited by 109
Bacteria in gene therapy: bactofection versus alternative gene therapy
Pálffy, R., Gardlík, R., Hodosy, J., Behuliak, M., Resko, P., Radvánský, J., & Celec, P. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302635 · Cited by 103
Peng, S., Ferrall, L., Gaillard, S. L., Wang, C., Chi, W.-Y., Huang, C., Roden, R. B. S., Wu, T. ‐., Chang, Y.-N., & Hung, C. (2021) · mBio · doi:10.1128/mbio.03224-20 · Cited by 100
PERMEABILITY PROPERTIES OF ERYTHROCYTE GHOSTS
Teorell, T. (1952) · The Journal of General Physiology · doi:10.1085/jgp.35.5.669 · Cited by 95
Silver nanoparticle based multifunctional approach for combating COVID-19
Allawadhi, P., Singh, V., Khurana, A., Khurana, I., Allwadhi, S., Kumar, P., Banothu, A. K., Thalugula, S., Barani, P. J., Naik, R. R., et al. (2021) · Sensors International · doi:10.1016/j.sintl.2021.100101 · Cited by 94
Self-citationAllawadhi, P., Singh, V., Govindaraj, K., Khurana, I., Sarode, L. P., Navik, U., Banothu, A. K., Weiskirchen, R., Bharani, K. K., & Khurana, A. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118923 · Cited by 93
Self-citationGene Delivery Using Herpes Simplex Virus Vectors
Burton, E. A., Fink, D. J., & Glorioso, J. C. (2002) · DNA and Cell Biology · doi:10.1089/104454902762053864 · Cited by 92
Methionine as a double-edged sword in health and disease: Current perspective and future challenges
Navik, U., Sheth, V. G., Khurana, A., Jawalekar, S. S., Allawadhi, P., Gaddam, R. R., Bhatti, J. S., & Tikoo, K. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101500 · Cited by 90
Self-citationLi, A., Zheng, N., & Ding, X. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10109-6 · Cited by 87
Laser-Based Gene Transfection and Gene Therapy
Yao, C., Zhang, Z., Rahmanzadeh, R., & Huettmann, G. (2008) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2008.2000742 · Cited by 86
Nanoceria as a possible agent for the management of COVID-19
Allawadhi, P., Khurana, A., Allwadhi, S., Joshi, K., Packirisamy, G., & Bharani, K. K. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100982 · Cited by 85
Self-citationO’Brien, J., & Lummis, S. C. R. (2011) · BMC Biotechnology · doi:10.1186/1472-6750-11-66 · Cited by 82
It’s all about the spaces between cells: role of extracellular matrix in liver fibrosis
Khurana, A., Sayed, N., Allawadhi, P., & Weiskirchen, R. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-2948 · Cited by 79
Self-citationMastorakos, P., Kambhampati, S. P., Mishra, M. K., Wu, T., Song, E., Hanes, J. S., & Kannan, R. M. (2014) · Nanoscale · doi:10.1039/c4nr04284k · Cited by 79
Barriers to Gene Delivery Using Synthetic Vectors
Read, M. L., Logan, A., & Seymour, L. W. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)53002-5 · Cited by 78
Gene Therapy of the Immune System
Cournoyer, D., & Caskey, C. T. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001501 · Cited by 77
New approaches to genetic therapies for cystic fibrosis
Boyd, A. C., Guo, S., Huang, L., Kerem, B., Oren, Y. S., Walker, A. J., & Hart, S. L. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.12.012 · Cited by 74
Carvalho, M. A. B. R., Sepodes, B. M. N., & Martins, A. P. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00182 · Cited by 73
Recent advances in the application of gene therapy to human disease
Hanania, E. G., Kavanagh, J. J., Hortobágyi, G. N., Giles, R. E., Champlin, R., & Deisseroth, A. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80232-0 · Cited by 72
Current Progress in Electrotransfection as a Nonviral Method for Gene Delivery
Cervia, L. D., & Yuan, F. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00207 · Cited by 69
Superoxide Dismutase Mimetic Nanoceria Restrains Cerulein Induced Acute Pancreatitis
Khurana, A., Anchi, P., Allawadhi, P., Kumar, V., Sayed, N., Packirisamy, G., & Godugu, C. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0318 · Cited by 60
Self-citationA novel method for DEAE-dextran mediated transfection of adherent primary cultured human macrophages
Mack, K. D., Wei, R., Elbaggari, A., Abbey, N. W., & McGrath, M. S. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00194-4 · Cited by 59
Allium sativum derived carbon dots as a potential theranostic agent to combat the COVID-19 crisis
Kalkal, A., Allawadhi, P., Pradhan, R., Khurana, A., Bharani, K. K., & Packirisamy, G. (2021) · Sensors International · doi:10.1016/j.sintl.2021.100102 · Cited by 57
Self-citationThe use of virus-like particles for gene transfer.
Petry, H., Goldmann, C., Ast, O., & Lüke, W. (2003) · PubMed · Cited by 56
The challenge of gene therapy and DNA delivery
Phillips, A. J. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776603 · Cited by 54
Tanyi, J. L., Chiang, C. L.-L., Chiffelle, J., Thierry, A., Baumgartener, P., Huber, F., Goepfert, C., Tarussio, D., Tissot, S., Torigian, D. A., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00297-5 · Cited by 54
Adverse effects of gene therapy: gene therapy can cause leukaemia: no shock, mild horror but a probe
Gore, M. E. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301946 · Cited by 53
Smith, A. R., Schiller, G. J., Vercellotti, G. M., Kwiatkowski, J. L., Krishnamurti, L., Esrick, E. B., Williams, D. A., Miller, W. P., Woolfson, A., & Walters, M. C. (2019) · Blood · doi:10.1182/blood-2019-125743 · Cited by 52
Evolution of Adenoviruses as Gene Therapy Vectors
Roy‐Chowdhury, J., & Horwitz, M. S. (2002) · Molecular Therapy · doi:10.1006/mthe.2001.0575 · Cited by 51
How safe is a popular gene therapy vector?
Kaiser, J. (2020) · Science · doi:10.1126/science.367.6474.131 · Cited by 51
Physical Methods for Gene Transfer
Alsaggar, M., & Liu, D. (2014) · Advances in genetics · doi:10.1016/bs.adgen.2014.10.001 · Cited by 48
Gene Therapy: Promises, Problems and Prospects
Verma, I. M., Naldini, L., Kafri, T., Miyoshi, H., Takahashi, M., Blömer, U., Somia, N. V., Wang, L., & Gage, F. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-56947-0_13 · Cited by 48
Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer
Kerr, M. D., McBride, D. A., Chumber, A. K., & Shah, N. J. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1811673 · Cited by 42
Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases
Singh, V., Khurana, A., Allawadhi, P., Banothu, A. K., Bharani, K. K., & Weiskirchen, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.790963 · Cited by 41
Self-citationPharmaceutical Biotechnology: Fundamentals and Applications
Mazza, P. G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6486-0 · Cited by 38
Influenza Virus RNA Synthesis and the Innate Immune Response
Weis, S., & Velthuis, A. J. W. T. (2021) · Viruses · doi:10.3390/v13050780 · Cited by 38
A role for adeno-associated viral vectors in gene therapy
Coura, R., & Nardi, N. B. (2008) · Genetics and Molecular Biology · doi:10.1590/s1415-47572008000100001 · Cited by 37
miR-132/212 Impairs Cardiomyocytes Contractility in the Failing Heart by Suppressing SERCA2a
Lei, Z., Wahlquist, C., el Azzouzi, H., Deddens, J. C., Kuster, D. W. D., van Mil, A., Rojas‐Muñoz, A., Huibers, M. M. H., Mercola, M. A., de Weger, R. A., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.592362 · Cited by 37
Can bilirubin nanomedicine become a hope for the management of COVID-19?
Khurana, I., Allawadhi, P., Khurana, A., Srivastava, A., Navik, U., Banothu, A. K., & Bharani, K. K. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110534 · Cited by 36
Self-citationThe application of gene therapy in autoimmune diseases
Seroogy, C. M., & Fathman, C. G. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301111 · Cited by 35
WFH State‐of‐the‐art paper 2020: In vivo lentiviral vector gene therapy for haemophilia
Cantore, A., & Naldini, L. (2020) · Haemophilia · doi:10.1111/hae.14056 · Cited by 32
Decorin as a possible strategy for the amelioration of COVID-19
Allawadhi, P., Singh, V., Khurana, I., Rawat, P. S., Renushe, A. P., Khurana, A., Navik, U., Allwadhi, S., Karlapudi, S. K., Banothu, A. K., et al. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110612 · Cited by 32
Self-citationCationic lipid-mediated transfection in mammalian cells: “Lipofection”
Felgner, J. H., Martin, M. U., Tsai, Y.-L., & Felgner, P. L. (1993) · Methods in Cell Science · doi:10.1007/bf01667363 · Cited by 31
Herpes simplex virus vectors for gene therapy
Latchman, D. S. (1994) · Molecular Biotechnology · doi:10.1007/bf02824809 · Cited by 30
Improved intracellular delivery of peptide- and lipid-nanoplexes by natural glycosides
Weng, A., Manunta, M., Thakur, M., Gilabert‐Oriol, R., Tagalakis, A. D., Eddaoudi, A., Munye, M. M., Vink, C. A., Wiesner, B., Eichhorst, J., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.007 · Cited by 30
Singh, V., Allawadhi, P., Khurana, A., Banothu, A. K., & Bharani, K. K. (2021) · Sensors International · doi:10.1016/j.sintl.2021.100098 · Cited by 30
Self-citationCannon, P. M., Asokan, A., Czechowicz, A. D., Hammond, P. T., Kohn, D. B., Lieber, A., Malik, P., Marks, P. W., Porteus, M. H., Verhoeyen, E., et al. (2021) · Human Gene Therapy · doi:10.1089/hum.2020.263 · Cited by 29
Considering the potential for gene-based therapy in prostate cancer
Gregg, J. R., & Thompson, T. C. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00431-x · Cited by 29
GDNF signaling in subjects with minimal motor deficits and Parkinson's disease
Chu, Y., & Kordower, J. H. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105298 · Cited by 29
Gene Delivery into Mammalian Cells: An Overview on Existing Approaches Employed In Vitro and In Vivo
Hahn, P. F., & Scanlan, E. (2010) · Topics in current chemistry · doi:10.1007/128_2010_71 · Cited by 28
Cardiac Differentiation of Mesenchymal Stem Cells: Impact of Biological and Chemical Inducers
Ramesh, S., Govarthanan, K., Ostrovidov, S., Zhang, H., Hu, Q., Camci‐Unal, G., Verma, R. S., & Ramalingam, M. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10165-3 · Cited by 28
Viral Vector-Based Melanoma Gene Therapy
Hromić‐Jahjefendić, A., & Lundstrom, K. H. (2020) · Biomedicines · doi:10.3390/biomedicines8030060 · Cited by 27
Gene therapy for X-linked severe combined immunodeficiency: Historical outcomes and current status
Pai, S., & Thrasher, A. J. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.055 · Cited by 27
Stem cell and genetic therapies for the fetus
Flake, A. W. (2003) · Seminars in Pediatric Surgery · doi:10.1016/s1055-8586(03)00024-6 · Cited by 26
Extracellular and Intracellular Barriers to Non-Viral Gene Transfer
Lynn, F., & David, A. (2013) · InTech eBooks · doi:10.5772/54699 · Cited by 24
Zhang, X., Yang, Y., Kang, T., Wang, J., Yang, G., Yang, Y., Lin, X., Wang, L., Li, K., Liu, J., et al. (2021) · Small · doi:10.1002/smll.202100501 · Cited by 24
Next-generation sequencing for the diagnosis of hepatitis B: current status and future prospects
García-García, S., Cortese, M. F., Rodríguez-Algarra, F., Tabernero, D., Rando‐Segura, A., Quer, J., Buti, M., & Rodríguez‐Frias, F. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1913055 · Cited by 23
Bansal, R., Singh, A. K., Gandhi, R. P., Pant, A. B., Kumar, P., & Gupta, K. C. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.05.001 · Cited by 22
Hall, S., & Agrawal, D. K. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0409-0 · Cited by 20
Development of Gene Therapy Vectors: Remaining Challenges
Gupta, V., Lourenço, S. P., & Hidalgo, I. J. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.11.035 · Cited by 20
Versatility of gene therapy vectors through viruses
Barzon, L., Stefani, A., Pacenti, M., & Palù, G. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.5.639 · Cited by 19
Research on genodermatoses using novel genome‐editing tools
Lehmann, J., Seebode, C., & Emmert, S. (2017) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13270 · Cited by 19
Nanoyttria Attenuates isoproterenol-induced Cardiac Injury
Godugu, C., Kumari, P., & Khurana, A. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0223 · Cited by 19
Self-citationIncreasing the bactofection capacity of a mammalian expression vector by removal of the f1 ori
Johnson, S. A., Ormsby, M. J., McIntosh, A., Tait, S. W. G., Blyth, K., & Wall, D. M. (2018) · Cancer Gene Therapy · doi:10.1038/s41417-018-0039-9 · Cited by 16
The scope of gene therapy in humans: scientific, safety and ethical considerations
Karpati, G., & Lochmüller, H. (1997) · Neuromuscular Disorders · doi:10.1016/s0960-8966(97)00051-5 · Cited by 15
Hong, W., Huang, M., Wei, Y., & Wei, X. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1576-0 · Cited by 10
Current strategies of virotherapy in clinical trials for cancer treatment
Lin, W., Zhao, Y., & Zhong, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26947 · Cited by 10
Cited by
Multifunctional mesoporous silica nanoparticles for biomedical applications
Xu, B., Li, S., Shi, R., & Liu, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01654-7 · Cited by 433
Metadata
- Authors
- Sayed, N., Allawadhi, P., Khurana, A., Singh, V., Navik, U., Pasumarthi, S. K., Khurana, I., Banothu, A. K., Weiskirchen, R., & Bharani, K. K.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 294
- Pages
- 120375
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W4210599569
- Cited by
- 337
- References
- 163
- FWCI
- 37.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.